Ascendis Pharma A/S (ASND)

Ascendis Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	559.54	392.16	444.77	446.27	584.52
Short-Term Investments	-	7.28	290.69	235.8	134.28
Cash & Short-Term Investments	559.54	399.44	735.46	682.06	718.8
Cash Growth	40.08%	-45.69%	7.83%	-5.11%	20.18%
Accounts Receivable	166.28	35.87	11.91	2.2	0.39
Other Receivables	11.16	19.9	13.72	20.99	6.96
Receivables	177.44	55.77	25.63	23.19	7.34
Inventory	295.61	208.93	130.67	75.41	-
Prepaid Expenses	28.27	38.58	31.72	25.23	13.99
Total Current Assets	1,061	702.72	923.47	805.89	740.13
Property, Plant & Equipment	98.71	110.63	129.1	126.05	108.11
Long-Term Investments	13.58	5.69	30.42	145.91	124.46
Goodwill	3.5	3.5	-	3.5	3.5
Other Intangible Assets	0.53	0.92	4.83	1.78	2.22
Other Long-Term Assets	2.32	2.13	1.92	1.81	1.38
Total Assets	1,179	825.59	1,090	1,085	979.79
Accounts Payable	96.39	94.57	101.03	59.42	21.9
Accrued Expenses	67.96	41.18	31.99	29.95	23.38
Current Portion of Long-Term Debt	476.05	407.1	399.19	-	-
Current Portion of Leases	15.48	14.17	13.79	7	6.86
Current Income Taxes Payable	1.22	2.3	5.49	0.2	0.3
Current Unearned Revenue	0.94	1.18	-	2.6	0.36
Other Current Liabilities	249.82	176.02	165.29	1.19	-
Total Current Liabilities	907.86	736.51	716.78	100.36	52.8
Long-Term Debt	287.53	138.38	-	-	-
Long-Term Leases	77.55	84.62	95.4	97.97	85.12
Long-Term Unearned Revenue	5	5.95	14.21	2.96	-
Long-Term Deferred Tax Liabilities	7.26	5.83	-	-	-
Other Long-Term Liabilities	-	-	-	-	3.16
Total Liabilities	1,285	971.28	826.39	201.29	141.08
Common Stock	8.15	7.75	7.68	7.65	7.22
Additional Paid-In Capital	2,444	2,123	2,113	2,108	1,729
Retained Earnings	-2,560	-2,277	-1,860	-1,236	-1,030
Treasury Stock	-0.11	-0.15	-0.15	-0.02	-
Comprehensive Income & Other	1.78	0.72	3.45	3.78	133.03
Shareholders' Equity	-105.71	-145.7	263.35	883.64	838.71
Total Liabilities & Equity	1,179	825.59	1,090	1,085	979.79
Total Debt	856.62	644.27	508.38	104.96	91.98
Net Cash (Debt)	-297.07	-244.83	234.57	684.66	742.1
Net Cash Growth	-	-	-65.74%	-7.74%	32.17%
Net Cash Per Share	-5.13	-4.35	4.18	12.50	14.66
Filing Date Shares Outstanding	59.84	56.61	56.04	56.78	53.75
Total Common Shares Outstanding	59.84	56.61	56.04	56.78	53.75
Working Capital	153	-33.79	206.69	705.53	687.33
Book Value Per Share	-1.77	-2.57	4.70	15.56	15.60
Tangible Book Value	-109.73	-150.12	258.52	878.36	832.99
Tangible Book Value Per Share	-1.83	-2.65	4.61	15.47	15.50
Machinery	32.91	38.86	-	25.77	19.8
Leasehold Improvements	20.3	19.38	-	18.07	8.54

Source: S&P Capital IQ. Standard template. Financial Sources.